ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 2922 • 2016 ACR/ARHP Annual Meeting

    Disability, Fatigue, and Their Associates in Early Diffuse Cutaneous Systemic Sclerosis

    Ariane L. Herrick1, Sébastien Peytrignet2, Xiaoyan Pan3, Roger Hesselstrand4, Luc Mouthon5, László Czirják6, Madelon C. Vonk7, Oliver Distler8, Joerg H.W Distler9, Edith Brown3, Kim Fligelstone3, Rachel Ochiel10, William Gregory11, Alan Silman12, Mark Lunt13 and Christopher Denton14, 1Centre for Musculoskeletal Research, University of Manchester, MAHSC, Salford Royal Hospital, Manchester, United Kingdom, 2Manchester Academic Health Sciences Centre, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 3Manchester Academic Health Science Centre, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 4Department of Rheumatology, Lund University, Lund, Sweden, 5Internal Medicine, Hopital Cochin, Paris, France, 6Department of Rheumatology and Immunology, University of Pécs, Faculty of Medicine, Pécs, Hungary, 7Department of the Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 8Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 9Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany, 10Royal Free London NHS Foundation Trust, London, United Kingdom, 11Rehabilitation Services, Salford Royal NHS Foundation Trust, Salford, United Kingdom, 12Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 13Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, 14Centre for Rheumatology, Royal Free Hospital, London, Great Britain

    Background/Purpose: ESOS (European Scleroderma Observational Study) was a prospective observational study of 326 patients with early diffuse cutaneous systemic sclerosis (dcSSc) from 50 centres. Here…
  • Abstract Number: 3235 • 2016 ACR/ARHP Annual Meeting

    Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus: Up to 7 Years of Treatment Exposure

    Vibeke Strand1, Pam Berry2, Sulabha Ramachandran2 and James Fettiplace3, 1Stanford University School of Medicine, Palo Alto, CA, 2GSK, Philadelphia, PA, 3GSK, Uxbridge, Middlesex, United Kingdom

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that causes long-term organ damage over time and impairment in health-related quality of life (HRQoL).…
  • Abstract Number: 531 • 2016 ACR/ARHP Annual Meeting

    Disease Activity and Physical Fatigue As Related to Adherence and Health Literacy in Patients with Rheumatoid Arthritis

    Jens Gert Kuipers1, Michael Koller2, Florian Zeman2, Karolina Mueller3 and Ulrich Rueffer4, 1Department of Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, 2Center of Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 3Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 4German Fatigue Society, Cologne, Germany

    Disease activity and physical fatigue as related to adherence and health literacy in patients with rheumatoid arthritis J. G. Kuipers1, M. Koller2, F. Zeman2, K.…
  • Abstract Number: 887 • 2016 ACR/ARHP Annual Meeting

    Fatigue and Physical Functioning in Patients with Giant Cell Arteritis

    Gunnar Tomasson1, John T. Farrar2, David Cuthbertson3, Susan Ashdown4, Don Gebhart5, Georgia Lanier6, Nataliya Milman7, Jacqueline Peck4, Joanna C. Robson8,9, Judy A. Shea10, Simon Carette11, Gary S. Hoffman12, Nader A. Khalidi13,14, Curry L. Koening15, Carol A. Langford16, Carol A McAlear17, Paul A. Monach18, Larry W. Moreland19, Christian Pagnoux20, Antoine G. Sreih21, Kenneth J. Warrington22, Steven R. Ytterberg23 and Peter A. Merkel24, 1Dept of Public Health Sciences, University of Iceland, Reykjavik, IS, 2University of Pennsylvania, Philadelphia, PA, 3Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, 4Oxford, Oxford, United Kingdom, 5Columbus, Columbus, OH, 6NONE, Framingham, MA, 7University of Ottawa Department of Medicine, University of Ottawa Division of Rheumatology, Ottawa, ON, Canada, 8School of Clinical Sciences, University of Bristol, Bristol, United Kingdom, 9Faculty of Health and Applied Science, University of the West of England, Bristol, United Kingdom, 10Division of General Internal Medicine, University of Pennsylvania, Philadelphia, PA, 11Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 12Rheumatology, Cleveland Clinic, Cleveland, OH, 13Rheumatology, McMaster University, Hamilton, ON, Canada, 14Division of Rheumatology, McMaster University, Hamilton, ON, Canada, 15Rheumatology, University of Utah, Salt Lake City, UT, 16Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 17Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 18Rheumatology, Boston University School of Medicine, Boston, MA, 19Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 20Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 21Rheumatology, The University of Pennsylvania, Philadelphia, PA, 22Rheumatology, University of California Los Angeles, CA, USA Mayo, Rochester, MN, 23Rheumatology, Mayo Clinic, Rochester, MN, 24Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

       Background/Purpose: Physical function is an established outcome measure for many rheumatic diseases and fatigue is a common disease manifestation across most, if not all,…
  • Abstract Number: 1055 • 2016 ACR/ARHP Annual Meeting

    Physical Activity Behavior in Men with Inflammatory Arthritis: A Cross-Sectional Register Based Study of Physical Activity Correlates, Motivators, Barriers and Preferences

    Nanna Maria Hammer1, Julie Midtgaard2, Merete Lund Hetland3,4, Niels Steen Krogh5 and Bente Appel Esbensen1,6, 1Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark, The DANBIO registry and Copenhagen Center for Arthritis Research, Glostrup, Denmark, 2Section of Social Medicine, University of Copenhagen, Copenhagen, Denmark, Department of Public Health, Copenhagen, Denmark, 3Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Copenhagen, Denmark, 4Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 5Zitelab, Frederiksberg, Denmark, 6Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen, Denmark, Copenhagen, Denmark

    Background/Purpose: While physical activity (PA) has been recommended as a part of the non-pharmacological management of inflammatory arthritis (IA), previous research within this area has…
  • Abstract Number: 1058 • 2016 ACR/ARHP Annual Meeting

    Adjustment Profiles Comprising Objective and Subjective Measures in Fibromyalgia Patients

    Fernando Estévez-López1,2, Inmaculada C Álvarez Gallardo1, Víctor Segura-Jiménez1,3, Milkana Borges-Cosic1, Manuel Pulido-Martos4, Ana Carbonell-Baeza3, Virginia A Aparicio1,5, Rinie Geenen2 and Manuel Delgado-Fernández1, 1University of Granada, Granada, Spain, 2Utrecht University, Utrecht, Netherlands, 3University of Cádiz, Cádiz, Spain, 4University of Jaén, Jaén, Spain, 5VU University Medical Care, Amsterdam, Netherlands

    Background/Purpose: Only one-third of FM patients obtain benefits after receiving one of the available therapy modalities. Insights into the heterogeneous picture of FM might improve…
  • Abstract Number: 1525 • 2016 ACR/ARHP Annual Meeting

    Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA

    Susan J. Bartlett1, Michelle Jones2 and Clifton Bingham III3, 1Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose:  Some view fatigue as resulting from disease activity, while others see it as a natural consequence of the pain, disability, and the emotional burden…
  • Abstract Number: 1534 • 2016 ACR/ARHP Annual Meeting

    Assessment of the Relationship of the Static and Dynamic Balance Parameters with Clinical, Functional and Radiological Findings in Patients with Rheumatoid Arthritis

    Canan Sanal Top1, M Tuncay Duruoz2 and Osman Hakan Gunduz3, 1PMR Department, Marmara University School of Medicine, Istanbul, Turkey, 2PMR Department, Rheumatology Division, Marmara University School of Medicine, Sisli-Istanbul, Turkey, 3Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey

    Background/Purpose:  Lower extremity arthritis, proprioceptive dysfunction related to foot deformities, muscle weakness, joint restrictions, biomechanical disoerders, fatigue, sleep disorders, depression, and pain are frequently seen…
  • Abstract Number: 1541 • 2016 ACR/ARHP Annual Meeting

    Frailty Is Associated with Decreased Physical Function in Adults with Rheumatoid Arthritis

    James Andrews1, Ken Covinsky2, Catherine Hough1, Laura Trupin3, Edward H. Yelin3 and Patricia P. Katz3, 1Medicine, University of Washington, Seattle, WA, 2Medicine, University of California San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Reduced physical function and health-related quality of life remain common in Rheumatoid Arthritis (RA), and further studies are needed that examine potential, novel determinates…
  • Abstract Number: 1548 • 2016 ACR/ARHP Annual Meeting

    Correlates of Fatigue in People Living with Rheumatoid Arthritis

    Jet Veldhuijzen van Zanten1,2, Sally Fenton3,4, Peter Rouse5, George Metsios3,6, Ahmad Osailan1,2, Chen-an Yu2, Nikos Ntoumanis7, Joan Duda4 and George Kitas1,2, 1Department of Rheumatology, Dudley Group NHS Foundation Trust, Dudley, United Kingdom, 2School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom, 3Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, 4School of Sport, Exercise and Rehabilitation, University of Birmingham, Birmingham, United Kingdom, 5Department for Health, University of Bath, Bath, United Kingdom, 6Department of Physical Activity Exercise and Health, University of Wolverhampton, Walsall, United Kingdom, 7School of Psychology & Speech Pathology, Curtin University, Perth, Australia

    Background/Purpose:  Fatigue is a frequently mentioned symptom by people living with rheumatoid arthritis (RA). However, little research has explored the associations between fatigue and other…
  • Abstract Number: 1763 • 2016 ACR/ARHP Annual Meeting

    Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients with Systemic Lupus Erythematosus Following 7 Years of Treatment Exposure: Impact of Clinical Characteristics over Time

    Vibeke Strand1, Pam Berry2, Xiwu Lin2, Yumi Asukai3, James Fettiplace3 and Sulabha Ramachandran2, 1Stanford University School of Medicine, Palo Alto, CA, 2GSK, Philadelphia, PA, 3GSK, Uxbridge, Middlesex, United Kingdom

    Background/Purpose: Despite improvements in medical care leading to improved survival, systemic lupus erythematosus (SLE) adversely affects patients’ health related quality of life (HRQoL). To explore…
  • Abstract Number: 2335 • 2015 ACR/ARHP Annual Meeting

    How Much Does Fatigue Contribute to the Physician and Patient Global Estimates in Different Rheumatic Diseases? Analysis from Routine Care on a Multidimensional Health Assessment Questionnaire (MDHAQ)

    Isabel Castrejón1, Elena Nikiphorou2, Ruchi Jain1, Annie Huang1, Joel A. Block3 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Addenbrooke's Hospital, Cambridge, United Kingdom, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Fatigue is an important problem for many patients with rheumatic diseases. Fatigue is associated with disease severity, psychological distress, and a poorer quality of…
  • Abstract Number: 2337 • 2015 ACR/ARHP Annual Meeting

    Depression, Bad Sleep Quality, and Functional Deficit Are Independently Associated with Persistent Fatigue in Arthritic Patients with Low Disease Activity Under Biological Dmards

    Vitalie Nizeica1, Myriam Normand2, Delphine Denarie1, Béatrice Pallot Prades1, Philippe Collet1, Adamah Amouzougan1, Hervé Locrelle1,2, Thierry Thomas1,2 and Hubert Marotte1,2, 1Rheumatology Department, University Hospital of Saint-Etienne, Saint-Etienne, France, 2INSERM U1059/LBTO, Université de Lyon - Université Jean Monnet, Saint-Etienne, France

    Background/Purpose: In rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) patients, fatigue has been mainly related to disease activity. Current management of rheumatic inflammatory diseases aims…
  • Abstract Number: 2637 • 2015 ACR/ARHP Annual Meeting

    Prevalence of Unacceptable Pain and the Risk of Fatigue and Sleeping Problems in Early Rheumatoid Arthritis Patients

    Joakim Lindqvist1, Maria Sandberg2,3, Saedis Saevarsdottir4, Reem Altawil4, Lars Klareskog5, Lars Alfredsson6 and Jon Lampa7, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, 2Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Karolinska Institutet, Stockholm, Sweden, 3The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 4Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 5Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden, 6Unit of Cardiovascular Epidemiology, Institute of Enviornmental Medicine, Karolinska Institutet, Karolinska Institutet, Stockholm, Sweden, 7Dep of Medicine, Rheumatology unit, Karolinska Institute, Karolinska Institute, Stockholm, Sweden

    Background/Purpose: Pain is a commonly reported cause of affliction in RA-patients, also after adequate anti-rheumatic treatment. The objective of this study was to investigate the…
  • Abstract Number: 2638 • 2015 ACR/ARHP Annual Meeting

    Multiple Psychosocial Factors Influence Subjective Assessments of Disease Activity in Rheumatoid Arthritis

    Ying L. Liu1, Joan M. Bathon2,3 and Jon T. Giles4, 1Internal Medicine, Columbia University Medical Center, New York, NY, 2Medicine, Columbia University, College, New York, NY, 3Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 4Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY

    Background/Purpose: Measuring disease activity in rheumatoid arthritis (RA) is important in evaluating efficacy of treatments, but many tests are subjective and lead to discordance in…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology